Am 03/25/17 um 07:17 schrieb Hervé BOUTEMY: > MNG-6112 is harder to estimate side effects IMHO > and since this has been available for a long time, I'm really not satisfied > that it has been integrated *after vote for 3.0.5-beta-1 started* (and in > addition without any discussion)
Issue has been mentioned by Michael Osipov somewhen during development of 3.4.0 in MNG-4645. I just created a separate issue in JIRA for it. There has been a discussion. There also has been an in depth search starting from GIT back to the initial commit in subversion by me documented in MNG-4645. <https://issues.apache.org/jira/browse/MNG-4645> > > I'd say punt to 3.5.1: benefit is not worth the risk for now (we lived for > years with that, we can stay with it for a couple of months to have wider > tests) Last time I looked at it, Maven never updated release versions. Commit is just making this explicit in the repository declaration. This sentence "There are still 10 issues left in JIRA for 3.5.0," in the vote email for beta-1 made me look at the list. I thought we already agreed to these issues for 3.5.0 and just wanted to close the remaining issues assigned to me. Regards, -- Christian --------------------------------------------------------------------- To unsubscribe, e-mail: dev-unsubscr...@maven.apache.org For additional commands, e-mail: dev-h...@maven.apache.org
